For­mer Im­munomedics CFO Us­ama Ma­lik re­sponds to in­sid­er trad­ing charges af­ter 'my ca­reer and ... rep­u­ta­tion ...

4 years ago
People

Biotech start­up lines up more cash to steer its NASH drug through stormy seas

4 years ago
Financing

Roche's Spark in­vests $575M for new gene ther­a­py cen­ter in cen­tral Philadel­phia as part of Drex­el part­ner­ship

4 years ago
Cell/Gene Tx

Pfiz­er plans to study a third shot for its Covid-19 vac­cine in the youngest kids, push­ing back its time­line far­ther

4 years ago
Coronavirus

Omega Funds goes back to the well with newest $650M fund, tak­ing a 'stage-ag­nos­tic' ap­proach to biotech VC

4 years ago
Financing

Deal­ing Bio­gen an­oth­er blow, EMA rec­om­mends re­ject­ing Aduhelm in three terse para­graphs

4 years ago
FDA+

Amy­lyx takes its ALS pro­gram to Nas­daq, rais­ing the stakes for the biotech's on­ly drug

4 years ago
Financing

Covid-19 roundup: CDC rec­om­mends mR­NA vac­cines over J&J’s due to rare blood clots; EU con­sid­ers deal for ...

4 years ago
Coronavirus

FDA per­ma­nent­ly lifts in-per­son re­quire­ments for dis­pens­ing abor­tion pills

4 years ago
FDA+

No­var­tis di­als up lung can­cer ‘Sound Up’ cam­paign to push back against stig­ma

4 years ago
Pharma
Marketing

Ipsen fronts $136M to bag Gen­fit's once-failed NASH drug, bet­ting on its po­ten­tial in rare liv­er con­di­tion

4 years ago
Deals

Sara Kenkare-Mi­tra leaves Genen­tech for a chance to lead neu­ro R&D; Glax­o­SmithK­line alum jumps to Vi­for Phar­ma with ...

4 years ago
Peer Review

Buoyed by semaglu­tide suc­cess, No­vo Nordisk un­corks plans for $2.58B man­u­fac­tur­ing ex­pan­sion in Den­mark

4 years ago
Manufacturing

Days af­ter buy­out news, Vi­for out­lines plan to of­fload 'non-core' fin­ished drug man­u­fac­tur­ing wing

4 years ago
R&D
Manufacturing

Pfiz­er opens doors at newest gene ther­a­py site in NC as part of $800M push in­to next-gen drugs

4 years ago
Cell/Gene Tx
Manufacturing

Sin­ga­pore to get a new man­u­fac­tur­ing, R&D site to fight help in­fec­tious dis­eases

4 years ago
Manufacturing

Drug­mak­ers seek tweaks to ICH guid­ance on con­tin­u­ous man­u­fac­tur­ing

4 years ago
Manufacturing

Oren­cia ap­proved by FDA for new in­di­ca­tion — graft vs host dis­ease; So­sei and Twist an­nounce an­ti­body dis­cov­ery ...

4 years ago
News Briefing

Af­ter 7 years in stealth, UC Berke­ley spin­out Nodexus emerges with an RA Cap­i­tal-backed Se­ries A

4 years ago
Financing
Startups

The next-gen IL-2 race heats up as Anaveon se­cures a megaround with its sights set on mid-stage tests

4 years ago
Financing

US black­lists Chi­nese re­search in­sti­tutes over 'brain con­trol' ef­forts as in­vestor frets roil biotech stocks

4 years ago
China
Pharma

Hori­zon hits the gas ped­al on re­newed ear­ly-stage R&D, en­list­ing a Mitch Gold biotech in a $1.5B+ deal

4 years ago
Deals

IN8bio's 'off-the-shelf' gam­ma delta T cells stave off re­lapse for high-risk leukemia pa­tients in very ear­ly da­ta cut

4 years ago
R&D
Cell/Gene Tx

Un­co­or­di­nat­ed and re­dun­dant: FDA's Paz­dur slams check­point in­hibitor de­vel­op­ers for cre­at­ing a 'Wild West'

4 years ago
R&D
China
First page Previous page 599600601602603604605 Next page Last page
A service from the Financial Times